The Concentration Monitoring of Safty for Xuebijing TCM Injection

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-13003574

Enrollment

Unknown

Registered

2013-09-12

Start date

2013-09-29

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infectious diseases

Interventions

none:xuebijing TCM injection

Eligibility

Sex/Gender

All

Age

No minimum to 95 Years

Inclusion criteria

Inclusion criteria: all the patients that use the Xuebijing TCM injection

Exclusion criteria

Exclusion criteria: the patients that have xuebijing TCM injection allergy histroy

Design outcomes

Primary

Measure	Time frame
ADR;	—

Countries

China

Contacts

Public ContactShang Hongcai

Tianjin University of TCM

shanghongcai@foxmail.com+86 15822772648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026